DMD and Duchenne muscular dystrophy: Based on its simplicity and precision, CRISPR-mediated genome engineering offers a promising therapeutic approach to restoring dystrophin expression and muscular functions in DMD individuals via eliminating pathological mutations at the genomic level [29,30].